Who’s Hired? O’Brien To Replace Richards As Mayne Pharma CEO

Plus Hikma Appoints New Board Members And Mallinckrodt Welcomes New CCO

Mayne Pharma has announced the appointment of pharma industry veteran Shawn O’Brien as CEO, replacing outgoing delegate Scott Richards. Plus, Hikma has appointed two new female board members, in line with gender diversity targets set by the UK Financial Conduct Authority.

Shawn O'Brien headshot
Shawn O'Brien has over 35 years of pharmaceutical industry experience • Source: Mayne Pharma

More from Leadership

More from Generics Bulletin